The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis.
作者信息
Pelfrene Eric, Harvey Allchurch Martin, Ntamabyaliro Nsengi, Nambasa Victoria, Ventura Fátima V, Nagercoil Nithyanandan, Cavaleri Marco
机构信息
Office of Anti-infectives and Vaccines, Human Medicines Evaluation Division, European Medicines Agency (EMA), Amsterdam, The Netherlands.
International Affairs Division, European Medicines Agency (EMA), Amsterdam, The Netherlands.
出版信息
PLoS Negl Trop Dis. 2019 Jun 27;13(6):e0007381. doi: 10.1371/journal.pntd.0007381. eCollection 2019 Jun.
Abstract
摘要
相似文献
1
The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis.欧洲药品管理局关于口服非昔硝唑用于治疗人类非洲锥虫病的科学意见。
PLoS Negl Trop Dis. 2019 Jun 27;13(6):e0007381. doi: 10.1371/journal.pntd.0007381. eCollection 2019 Jun.
2
Fexinidazole: First Global Approval.非硝唑：全球首次获批。
Drugs. 2019 Feb;79(2):215-220. doi: 10.1007/s40265-019-1051-6.
3
Fexinidazole for the treatment of human African trypanosomiasis.非昔硝唑用于治疗人类非洲锥虫病。
Drugs Today (Barc). 2019 Nov;55(11):705-712. doi: 10.1358/dot.2019.55.11.3068795.
4
Fexinidazole: A New Drug for African Sleeping Sickness on the Horizon.非昔硝唑：一种有望用于治疗非洲昏睡病的新药。
Trends Parasitol. 2018 Mar;34(3):178-179. doi: 10.1016/j.pt.2017.12.002. Epub 2017 Dec 20.
5
Fexinidazole and Human African Trypanosomiasis: good news for this important neglected tropical disease.非昔硝唑与人类非洲锥虫病：对这种重要的被忽视热带病来说是个好消息。
Rev Soc Bras Med Trop. 2019 Oct 3;52:e20190176. doi: 10.1590/0037-8682-0176-2019. eCollection 2019.
6
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.口服非昔硝唑治疗晚期非洲冈比亚锥虫布氏锥虫病：一项关键性多中心、随机、非劣效性试验。
Lancet. 2018 Jan 13;391(10116):144-154. doi: 10.1016/S0140-6736(17)32758-7. Epub 2017 Nov 4.
7
Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trial.口服非昔硝唑治疗冈比亚锥虫病儿童的安全性和有效性：一项多中心、单臂、开放标签、2-3 期临床试验。
Lancet Glob Health. 2022 Nov;10(11):e1665-e1674. doi: 10.1016/S2214-109X(22)00338-2. Epub 2022 Sep 27.
8
Second stage human African Trypanosomiasis with Trypanosoma brucei rhodesiense treated with fexinidazole.用非昔硝唑治疗的罗德西亚布氏锥虫所致的二期人类非洲锥虫病
Lancet Infect Dis. 2023 Nov;23(11):e505. doi: 10.1016/S1473-3099(23)00358-4.
9
Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies.测定新型口服药物非昔硝唑治疗非洲人类锥虫病的最佳剂量方案：人体首次研究。
Clin Pharmacokinet. 2014 Jun;53(6):565-80. doi: 10.1007/s40262-014-0136-3.
10
Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole.新型苯并异喹啉类化合物非昔硝唑肝毒性和骨髓毒性的药代动力学-药效学评价。
Antimicrob Agents Chemother. 2019 Mar 27;63(4). doi: 10.1128/AAC.02515-18. Print 2019 Apr.
引用本文的文献
1
Multiparameter ranking of carbazoles for anti-trypanosome lead discovery.用于抗锥虫先导化合物发现的咔唑类化合物的多参数排名
Front Drug Discov (Lausanne). 2024;4. doi: 10.3389/fddsv.2024.1430927. Epub 2024 Aug 14.
2
Transforming the chemotherapy of human African trypanosomiasis.变革人类非洲锥虫病的化疗方法。
Clin Microbiol Rev. 2025 Mar 13;38(1):e0015323. doi: 10.1128/cmr.00153-23. Epub 2025 Jan 8.
3
Discovery of an orally active nitrothiophene-based antitrypanosomal agent.发现一种具有口服活性的硝基噻吩类抗利什曼原虫药物。
Eur J Med Chem. 2024 Jan 5;263:115954. doi: 10.1016/j.ejmech.2023.115954. Epub 2023 Nov 15.
4
Hypothesis-generating proteome perturbation to identify NEU-4438 and acoziborole modes of action in the African Trypanosome.用于生成假设的蛋白质组扰动，以确定非洲锥虫中NEU-4438和氨苯砜硼烷的作用模式。
iScience. 2022 Oct 7;25(11):105302. doi: 10.1016/j.isci.2022.105302. eCollection 2022 Nov 18.
5
Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer.隐品碱的半合成类似物作为治疗疟疾、人类非洲锥虫病和癌症的可持续药物的潜在来源
Front Pharmacol. 2022 Apr 26;13:875647. doi: 10.3389/fphar.2022.875647. eCollection 2022.
6
Chemotherapy for second-stage human African trypanosomiasis: drugs in use.第二期人体非洲锥虫病的化疗：使用中的药物。
Cochrane Database Syst Rev. 2021 Dec 9;12(12):CD015374. doi: 10.1002/14651858.CD015374.
7
Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.尼氟拉嗪依氟鸟氨酸联合疗法（NECT）在刚果民主共和国冈比亚锥虫病二期睡眠病患者中的疗效：现场研究报告。
PLoS Negl Trop Dis. 2021 Nov 8;15(11):e0009903. doi: 10.1371/journal.pntd.0009903. eCollection 2021 Nov.
8
New Series of Imidazoles Showed Promising Growth Inhibitory and Curative Potential Against Trypanosoma Infection.一系列新型咪唑类化合物在抑制和治疗锥虫感染方面显示出了良好的效果。
Yale J Biol Med. 2021 Jun 30;94(2):199-207. eCollection 2021 Jun.
9
Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial.多种无偏方法鉴定角鲨烯环氧化酶为一种有前景的抗利什曼原虫药物的作用靶点。
Cell Chem Biol. 2021 May 20;28(5):711-721.e8. doi: 10.1016/j.chembiol.2021.02.008. Epub 2021 Mar 9.
10
Discovery of Diaryl Ether Substituted Tetrahydrophthalazinones as TbrPDEB1 Inhibitors Following Structure-Based Virtual Screening.基于结构的虚拟筛选发现二芳基醚取代的四氢酞嗪酮作为TbrPDEB1抑制剂
Front Chem. 2021 Jan 21;8:608030. doi: 10.3389/fchem.2020.608030. eCollection 2020.
本文引用的文献
1
Oral fexinidazole for human African trypanosomiasis.口服非昔硝唑治疗人类非洲锥虫病。
Lancet. 2018 Jan 13;391(10116):100-102. doi: 10.1016/S0140-6736(18)30019-9.
2
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.口服非昔硝唑治疗晚期非洲冈比亚锥虫布氏锥虫病：一项关键性多中心、随机、非劣效性试验。
Lancet. 2018 Jan 13;391(10116):144-154. doi: 10.1016/S0140-6736(17)32758-7. Epub 2017 Nov 4.
3
Human African trypanosomiasis.非洲人类锥虫病。
Lancet. 2017 Nov 25;390(10110):2397-2409. doi: 10.1016/S0140-6736(17)31510-6. Epub 2017 Jun 30.
4
Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency.基于青蒿素的联合疗法治疗非复杂性疟疾：欧洲药品管理局近期监管经验综述
Int Health. 2015 Jul;7(4):239-46. doi: 10.1093/inthealth/ihv017. Epub 2015 Apr 8.
5
Registering medicines for low-income countries: how suitable are the stringent review procedures of the World Health Organisation, the US Food and Drug Administration and the European Medicines Agency?为低收入国家注册药品：世界卫生组织、美国食品和药物管理局以及欧洲药品管理局严格的审查程序有多合适？
Trop Med Int Health. 2014 Jan;19(1):23-36. doi: 10.1111/tmi.12201. Epub 2013 Oct 17.
6
Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study.一线依氟鸟氨酸治疗苏丹布氏冈比亚锥虫昏睡病的安全性和有效性：队列研究
BMJ. 2008 Mar 29;336(7646):705-8. doi: 10.1136/bmj.39485.592674.BE. Epub 2008 Mar 5.
7
Clinical aspects of 2541 patients with second stage human African trypanosomiasis.2541例二期人类非洲锥虫病患者的临床情况
Acta Trop. 2006 Jan;97(1):55-64. doi: 10.1016/j.actatropica.2005.08.001. Epub 2005 Sep 12.
Zotero 插件